Can Xu
- Gastroenterology top 1%
- Gastrointestinal Bleeding Diagnosis and Treatment 4
- Surgery top 5%
- Pancreatitis Pathology and Treatment 5
- Gastrointestinal disorders and treatments 3
- Esophageal Cancer Research and Treatment 3
- Bladder and Urothelial Cancer Treatments 2
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 7
-
- Gastric Cancer Management and Outcomes 4
-
- Neuroendocrine Tumor Research Advances 2
- Cited by
- GastroenterologySurgeryOncology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Can Xu
24 papers receiving 884 citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Gastroenterology 479
- Surgery 540
- Oncology 233
- Pulmonary and Respiratory Medicine 240
- Anesthesiology and Pain Medicine 18
Countries citing papers authored by Can Xu
This map shows the geographic impact of Can Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Xu more than expected).
Fields of papers citing papers by Can Xu
This network shows the impact of papers produced by Can Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Xu. The network helps show where Can Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Can Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 22 | |
| 6 | 2022 | 72 | |
| 7 | 2022 | 18 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 3 | |
| 10 | 2018 | 16 | |
| 11 | 2015 | 38 | |
| 12 | 2014 | 26 | |
| 13 | 2013 | 1 | |
| 14 | 2012 | 53 | |
| 15 | Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic reviewbreakdown → | 2010 | 474 |
| 16 | 2010 | 13 | |
| 17 | 2009 | 14 | |
| 18 | 2009 | 14 | |
| 19 | 2003 | 8 | |
| 20 | [Diagnosis and differential diagnosis of primary carcinoma of female peritoneum]. | 1999 | 1 |
About Can Xu
Can Xu is a scholar working on Gastroenterology, Surgery and Biological Psychiatry, having authored 26 papers that have together received 914 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Pancreatitis Pathology and Treatment (5 papers), Gastrointestinal Bleeding Diagnosis and Treatment (4 papers), Gastric Cancer Management and Outcomes (4 papers), Gastrointestinal disorders and treatments (3 papers), Esophageal Cancer Research and Treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Gastroenterology (479 citations), Surgery (540 citations) and Oncology (233 citations). Can Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Zhuan Liao, Zhao‐Shen Li, Rui Gao, Zhaoshen Li, Zhendong Jin, Minmin Zhang, Jianguo Yu, Chunguang Li, Yi‐Jun Wu and Yiqi Du. Their work appears in journals such as PLoS ONE, Chemical Engineering Journal and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.